{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T16:20:32Z","timestamp":1780503632489,"version":"3.54.1"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.canep.2019.101578","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T05:43:34Z","timestamp":1564638214000},"page":"101578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Natural killer cell activity and prostate cancer risk in veteran men undergoing prostate biopsy"],"prefix":"10.1016","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6624-9103","authenticated-orcid":false,"given":"Adriana C.","family":"Vidal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E.","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Wiggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"De Hoedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen L.","family":"Shiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Knott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Taioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay H.","family":"Fowke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8104-6419","authenticated-orcid":false,"given":"Stephen J.","family":"Freedland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2019.101578_bib0005","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1056\/NEJMra021562","article-title":"Prostate cancer","volume":"349","author":"Nelson","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canep.2019.101578_bib0010","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1158\/1055-9965.EPI-17-0503","article-title":"A prospective study of chronic inflammation in benign prostate tissue and risk of prostate cancer: linked PCPT and SELECT cohorts","volume":"26","author":"Platz","year":"2017","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.canep.2019.101578_bib0015","doi-asserted-by":"crossref","first-page":"22089","DOI":"10.1038\/srep22089","article-title":"Prognostic significance of neutrophil-to-lymphocyte ratio in prostate cancer: evidence from 16, 266 patients","volume":"6","author":"Gu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canep.2019.101578_bib0020","first-page":"581","article-title":"Neutrophil, lymphocyte and platelet counts, and risk of prostate cancer outcomes in white and black men: results from the SEARCH database","volume":"29","author":"Vidal","year":"2018","journal-title":"Cancer Causes Control: CCC"},{"key":"10.1016\/j.canep.2019.101578_bib0025","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1159\/000489400","article-title":"The change in neutrophil lymphocyte ratio from the first to the last repeat prostate biopsy proposed as a marker of carcinogenesis","volume":"101","author":"Hashimoto","year":"2018","journal-title":"Urol. Int."},{"key":"10.1016\/j.canep.2019.101578_bib0030","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1158\/0008-5472.CAN-15-1965","article-title":"Inherent and tumor-driven immune tolerance in the prostate microenvironment impairs natural killer cell antitumor activity","volume":"76","author":"Pasero","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.canep.2019.101578_bib0035","doi-asserted-by":"crossref","first-page":"14360","DOI":"10.18632\/oncotarget.3965","article-title":"Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer","volume":"6","author":"Pasero","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.canep.2019.101578_bib0040","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/j.celrep.2018.02.058","article-title":"Bimodal CD40\/Fas-dependent crosstalk between iNKT cells and tumor-associated macrophages impairs prostate cancer progression","volume":"22","author":"Cortesi","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.canep.2019.101578_bib0045","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41577-018-0061-z","article-title":"Natural killer cells and other innate lymphoid cells in cancer","volume":"18","author":"Chiossone","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canep.2019.101578_bib0050","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1226::AID-CNCR2>3.0.CO;2-G","article-title":"Natural killer cells and cancer","volume":"77","author":"Brittenden","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.canep.2019.101578_bib0055","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2302\/kjm.38.27","article-title":"Natural killer cell activity and recycling capacity of natural killer cells in patients with carcinoma of the prostate","volume":"38","author":"Marumo","year":"1989","journal-title":"Keio J. Med."},{"key":"10.1016\/j.canep.2019.101578_bib0060","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF00204990","article-title":"The relationship between clinical stage, natural killer activity and related immunological parameters in adenocarcinoma of the prostate","volume":"28","author":"Lahat","year":"1989","journal-title":"Cancer Immunol. Immunother. CII"},{"key":"10.1016\/j.canep.2019.101578_bib0065","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/pros.2990210204","article-title":"NK cell activity in treated prostate cancer patients as a probe for circulating tumor cells: hormone regulatory effects in vivo","volume":"21","author":"Kastelan","year":"1992","journal-title":"Prostate"},{"key":"10.1016\/j.canep.2019.101578_bib0070","first-page":"1671","article-title":"Analysis of NK cell activity, lymphocyte reactivity to mitogens and serotest PSA and TPS values in patients with primary and disseminated prostate cancer, PIN and BPH","volume":"17","author":"Kastelan","year":"1997","journal-title":"Anticancer Res."},{"key":"10.1016\/j.canep.2019.101578_bib0075","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078049","article-title":"Reduction of the CD16(-)CD56bright NK cell subset precedes NK cell dysfunction in prostate cancer","volume":"8","author":"Koo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.canep.2019.101578_bib0080","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jim.2018.04.002","article-title":"Quantification of NK cell activity using whole blood: methodological aspects of a new test","volume":"458","author":"Nederby","year":"2018","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.canep.2019.101578_bib0085","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22640","article-title":"Association of neutrophil-to-lymphocyte ratio and natural killer cell activity revealed by measurement of interferon-gamma levels in a healthy population","volume":"33","author":"Kim","year":"2019","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.canep.2019.101578_bib0090","first-page":"8708","article-title":"Association between natural killer cell activity and prostate cancer: a pilot study","volume":"24","author":"Barkin","year":"2017","journal-title":"Can. J. Urol."},{"key":"10.1016\/j.canep.2019.101578_bib0095","first-page":"3883","article-title":"The clinical usefulness of natural killer cell activity in patients with suspected or diagnosed prostate cancer: an observational cross-sectional study","volume":"11","author":"Song","year":"2018","journal-title":"Oncol. Ther."},{"key":"10.1016\/j.canep.2019.101578_bib0100","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(00)03231-1","article-title":"Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population","volume":"356","author":"Imai","year":"2000","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.canep.2019.101578_bib0105","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jim.2009.06.004","article-title":"Characterization of the intra-prostatic immune cell infiltration in androgen-deprived prostate cancer patients","volume":"348","author":"Gannon","year":"2009","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.canep.2019.101578_bib0110","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0065-2776(08)60664-1","article-title":"Biology of natural killer cells","volume":"47","author":"Trinchieri","year":"1989","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.canep.2019.101578_bib0115","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ccell.2017.06.009","article-title":"Control of metastasis by NK cells","volume":"32","author":"Lopez-Soto","year":"2017","journal-title":"Cancer Cell"}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187778211930089X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187778211930089X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:25:37Z","timestamp":1761801937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187778211930089X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":23,"alternative-id":["S187778211930089X"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2019.101578","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural killer cell activity and prostate cancer risk in veteran men undergoing prostate biopsy","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2019.101578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101578"}}